Your browser doesn't support javascript.
loading
Quality and rapidity of anticoagulation in patients with acute pulmonary embolism undergoing mechanical thrombectomy.
Zhang, Robert S; Ho, Alvin M; Elbaum, Lindsay; Greco, Allison A; Hall, Sylvie; Postelnicu, Radu; Mukherjee, Vikramjit; Maqsood, Muhammad H; Keller, Norma; Alviar, Carlos L; Bangalore, Sripal.
Afiliação
  • Zhang RS; Division of Cardiovascular Medicine, New York University, New York, NY.
  • Ho AM; Department of Medicine, New York University, New York, NY.
  • Elbaum L; Division of Cardiovascular Medicine, New York University, New York, NY.
  • Greco AA; Division of Pulmonary Critical Care, and Sleep Medicine, NYU Grossman School of Medicine, New York, NY.
  • Hall S; Division of Cardiovascular Medicine, New York University, New York, NY; Department of Pharmacy, Bellevue Hospital Center, New York, NY.
  • Postelnicu R; Division of Pulmonary Critical Care, and Sleep Medicine, NYU Grossman School of Medicine, New York, NY.
  • Mukherjee V; Division of Pulmonary Critical Care, and Sleep Medicine, NYU Grossman School of Medicine, New York, NY.
  • Maqsood MH; Department of cardiology, DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, TX.
  • Keller N; Division of Cardiovascular Medicine, New York University, New York, NY.
  • Alviar CL; Division of Cardiovascular Medicine, New York University, New York, NY.
  • Bangalore S; Division of Cardiovascular Medicine, New York University, New York, NY. Electronic address: sripalbangalore@gmail.com.
Am Heart J ; 267: 91-94, 2024 01.
Article em En | MEDLINE | ID: mdl-38071002
ABSTRACT
The primary objective of our study was to determine the proportion of intermediate-risk PE patients undergoing mechanical thrombectomy (MT) who achieved therapeutic anticoagulation (AC) at the time of the procedure. The salient findings of our study showed that only a minority of patients (14.3%) were in the therapeutic range by ACT at the time of MT (primary outcome). Furthermore, in this higher-risk PE cohort selected for MT, 18.2% of patients were subtherapeutic after initially reaching therapeutic AC, 43% experienced supratherapeutic AC at some point before MT, and less than half (43%) attained therapeutic AC at 6 hours, highlighting the necessity for optimizing anticoagulation practices in acute PE.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Embolia Pulmonar / Trombectomia Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Embolia Pulmonar / Trombectomia Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article